The FDA has recorded an action on a supplement to NDA212614, held by Boehringer Ingelheim for TRIJARDY XR — the fixed-dose combination of empagliflozin, linagliptin and metformin hydrochloride — dated 11 August 2026. It is one of a group of supplements recorded on the same day across related combination products.
The record names the application, the sponsor and the actives, and does not say what the supplement covers. Supplements on an established product are most often manufacturing or labelling changes; they can also add an indication or a strength. Nothing in the entry indicates a safety issue, and none of this changes how the product is prescribed today.
The reason to notice a cluster of supplements on fixed-dose combinations at all is the therapeutic question underneath them, which is live in Indian practice: whether to reach for a triple fixed-dose combination or to titrate components separately. Combinations improve adherence and reduce cost per tablet; they also make it harder to stop one component when eGFR falls, when a patient becomes volume-deplete, or when an SGLT2 inhibitor needs holding for sick days or surgery. That is a prescribing judgement, not a regulatory one, and this record does not bear on it either way.
- This is licence maintenance with no stated subject — not a new approval or a safety signal
- Check renal function before and during any metformin-containing combination
- Give sick-day rules explicitly: SGLT2 inhibitors should be held during acute illness, which is harder in a combination
- Combinations aid adherence but reduce flexibility when one component must stop
- The FDA record says nothing about Indian availability or CDSCO status for this product
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free